Evidence map›Paper›PMID 41366615›Full record

ArticleHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2026

Association Between Metabolic Syndrome Components, Clinical Characteristics, and Telomere Length: Factor Analysis of Mixed Data Based Cluster Analysis of LIPIDOGEN2015 Cross-Sectional Study.

Tadeusz Osadnik, Maciej Banach, Anna Goc, Ewa Boniewska-Bernacka, Anna Pańczyszyn, Marcin Goławski, Martyna Fronczek, Joanna Katarzyna Strzelczyk, Mateusz Lejawa, Marek Gierlotka and 8 more

Abstract read
In one paragraph

Article in High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Tadeusz OsadnikDepartment of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808, Katowice, Poland.
Maciej BanachDepartment of Preventive Cardiology and Lipidology, Medical University in Lodz (MUL), 93-338, Lodz, Poland.
Anna GocDepartment of Biology and Genetics, Faculty of Medicine, University of Opole, 45-052, Opole, Poland.
Ewa Boniewska-BernackaDepartment of Biology and Genetics, Faculty of Medicine, University of Opole, 45-052, Opole, Poland.
Anna PańczyszynDepartment of Biology and Genetics, Faculty of Medicine, University of Opole, 45-052, Opole, Poland.
Marcin GoławskiDepartment of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808, Katowice, Poland. martin.golawski@gmail.com.ORCID http://orcid.org/0000-0001-7891-672X
Martyna FronczekDepartment of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808, Katowice, Poland.
Joanna Katarzyna StrzelczykDepartment of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 19 Jordana St., 41-808, Zabrze, Poland.
Mateusz LejawaDepartment of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808, Katowice, Poland.
Marek GierlotkaDepartment of Cardiology, University Hospital, Institute of Medical Sciences, University of Opole, 45-401, Opole, Poland.
Kamila OsadnikDepartment of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808, Katowice, Poland.
Nikodem BaronDepartment of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808, Katowice, Poland.
Karol KrystekDepartment of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808, Katowice, Poland.
Agnieszka GachDepartment of Genetics, Polish Mother's Memorial Hospital-Research Institute, 93-338, Lodz, Poland.
Tomasz CzaporDepartment of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808, Katowice, Poland.
Natalia PawlasDepartment of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808, Katowice, Poland.
Francesco PaneniCenter for Translational and Experimental Cardiology, University Hospital Zurich, University of Zurich, 8952, Zurich, Switzerland.
Jacek JóźwiakDepartment of Family Medicine and Public Health, Faculty of Medicine, University of Opole, 45-040, Opole, Poland.

Funding

Śląski Uniwersytet Medyczny w Katowicach PCN-1-113/N/1IValeant Pharmaceuticals International Valeant Pharmaceuticals International
6 · The paper itself

Abstract

introductionTelomere length is an acclaimed marker of aging, which has been previously shown to correlate with cardiovascular diseases and metabolic syndrome traits.

aimTo identify the relationship between patient characteristics and telomere length.

methodsThe LIPIDOGEN was a random patient sample substudy of LIPIDOGRAM 2015 study (n = 13,724) conducted in primary care facilities in Poland. Data on risk factors, chronic diseases, treatment, and lifestyle were collected. Telomere length was determined with routine PCR from saliva. Factor Analysis for Mixed Data analysis was utilized to discern the principal components of patient clinical profiles. Furthermore, hierarchical clustering was used to obtain clusters of patients based on principal components.

results1556 patients (60% female, mean age 51 years) were included in the analysis after the exclusion of outliers and low DNA quality samples. Three clusters of patients were identified. Cluster 1 was characterized by low cardiovascular risk, without significant risk factors. Cluster 2 consisted of patients with a higher incidence of metabolic syndrome (MetS, 62%) and the highest smoking rate (22%). Cluster 3 had the highest incidence of MetS (94%), treatment with statin (62%), and diabetes mellitus (61%), and contained nearly all patients with myocardial infarction (17% of this cluster). Patients in Cluster 1 had significantly longer telomeres than patients in Cluster 2 and 3 (p = 0.01 and p < 0.001 respectively).

conclusionsThe pattern of clinical characteristics marked by classical cardiovascular risk factors including components of MetS, is inversely related to telomere length, underlining the potential role of metabolic disturbances in cellular aging.

Indexed as

LipidsMetabolic SyndromeTelomereTelomere HomeostasisAdultAgedCardiovascular DiseasesCluster AnalysisCross-Sectional StudiesFemaleHumansIncidenceMaleMiddle AgedPhenotypePolandLipidsCardiovascularFactorFAMDMixedTelomere

Identifiers

PMID41366615
PMCPMC12883513

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.